Archive: 15/04/2016
Patients with EGFR expressing NSCLC benefit most from necitumumab added to chemotherapy
Patients with epidermal growth factor receptor (EGFR) expressing advanced squamous non-small-cell lung cancer benefit most from necitumumab added to gemcitabine and cisplatin chemotherapy, according to a subgroup analysis ...
Apr 15, 2016
Plasma genotyping to predict treatment benefit in patients with NSCLC
The benefit of plasma genotyping to predict treatment benefit in patients with non-small-cell lung cancer (NSCLC) is confirmed in three studies presented today at the European Lung Cancer Conference (ELCC) 2016 in Geneva, ...
Apr 15, 2016
Studies demonstrate improved safety results achieved with investigational drug for hep B
Studies presented today at The International Liver Congress 2016 in Barcelona, Spain, demonstrate that tenofovir alafenamide (TAF) improves patient safety while maintaining efficacy in patients with chronic Hepatitis B virus ...
Apr 15, 2016
New treatment algorithm can predict benefit of treatment in end-stage liver disease
A new algorithm designed to help physician decision-making in End-Stage Liver Disease (ESLD), was able to accurately predict death in 96% of patients with ESLD.
Apr 15, 2016
Treatment for chronic hepatitis B linked to increased rates of colorectal and cervical cancer
A new study presented today demonstrates a potential link between treatment of long-term oral nucleos(t)ide analogues and an increased risk of colorectal (p=0.029) and cervical (p=0.049) cancer in patients with chronic Hepatitis ...
Apr 15, 2016
Additional benefits of type 2 diabetes treatment found for non-alcoholic fatty liver disease patients
A type 2 diabetes treatment has been found to also have 'off-label' benefits for glucose control in the liver and in fatty cells known as adipose.1 Presented at The International Liver Congress 2016 in Barcelona, Spain, today, ...
Apr 15, 2016
Antiviral therapy prolongs survival in immune tolerant hepatitis B patients
A new study, presented today at The International Liver Congress 2016 in Barcelona Spain, demonstrates that the use of antiviral therapy for patients in the immune tolerant phase of Hepatitis B (HBV) prolongs overall survival ...
Apr 15, 2016
Scientists uncover a potential approach to combat obesity in those prone to weight gain
For the first time scientists have kick-started the natural process by which genetically predisposed obese mice gain weight, opening up a new potential approach to fight off obesity. The study that was presented today at ...
Apr 15, 2016
Greek dancing improves jumping ability of elderly heart failure patients
Greek dancing improves the jumping ability of elderly patients with heart failure, according to research published today in the European Journal of Cardiovascular Nursing. Patients randomised to Greek dancing jumped higher ...
Apr 15, 2016